Patents Assigned to CSL Behring AG
  • Immunoglobulin fractions
    Patent number: 7887797
    Abstract: The present invention relates to novel pharmaceutical compositions comprising fractions of human immunoglobulin preparations, novel applications of these compositions and a method for manufacturing the compositions.
    Type: Grant
    Filed: October 27, 2005
    Date of Patent: February 15, 2011
    Assignee: CSL Behring AG
    Inventors: Sylvia Miescher, Reinhard Franz Bolli
  • Treatment of inflammatory conditions of the intestine
    Patent number: 7759315
    Abstract: A method for the treatment and/or prophylaxis of an inflammatory condition of the intestine of a patient, comprises parenteral administration to the patient of an effective amount of high density lipoprotein (HDL).
    Type: Grant
    Filed: March 9, 2005
    Date of Patent: July 20, 2010
    Assignee: CSL Behring AG
    Inventors: Salvatore Cuzzocrea, Christoph Thiemermann, Gillian Cockerill
  • HDL for the treatment of stroke and other ischemic conditions
    Patent number: 7491693
    Abstract: The present invention relates to a method for the prophylaxis and/or treatment of stroke and other ischemic injury, wherein HDL is administered to a subject in need thereof, particularly by intravenous infusion.
    Type: Grant
    Filed: May 4, 2007
    Date of Patent: February 17, 2009
    Assignee: CSL Behring AG
    Inventors: Alphonse Hubsch, Markus G. Lang